CTNNB1
CTNNB1 (catenin beta 1), also known as beta-catenin, armadillo and CTNNB, is a key downstream component of the canonical Wnt signalling pathway. It also serves as a structural component of adherens junctions, linking cell adhesion to the actin cytoskeleton. Browse Assay Genie's current range of CTNNB1 research reagents below, or read on for the biology behind the target.
CTNNB1 has two principal roles. In the canonical Wnt pathway, in the absence of Wnt it is held in a complex with AXIN1, AXIN2, APC, CSNK1A1 and GSK3B. This complex promotes phosphorylation of N-terminal serine and threonine residues, ubiquitination via BTRC and degradation by the proteasome. When a Wnt ligand is present, CTNNB1 is not ubiquitinated and accumulates in the nucleus. There it acts as a coactivator for TCF/LEF transcription factors and switches on Wnt-responsive genes. It can also coactivate other factors, such as NR5A2, and it promotes epithelial to mesenchymal and mesenchymal to epithelial transitions by driving transcription of TCF target genes.
At the cell surface, the CTNNB1 protein is part of the E-cadherin:catenin adhesion complex within adherens junctions. These junctions create and maintain epithelial cell layers by regulating cell growth and adhesion between cells. The protein anchors the actin cytoskeleton and may transmit the contact inhibition signal that stops cell division once an epithelial sheet is complete. UniProt also lists localisation to the centrosome, spindle pole, cilium basal body and synapse. It acts as a negative regulator of centrosome cohesion and takes part in the CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalisation.
Further annotated functions include blocking anoikis in malignant kidney and intestinal epithelial cells by down-regulating DAPK2, and promoting neurogenesis by keeping sympathetic neuroblasts in the cell cycle. CTNNB1 binds SOX9 during chondrocyte differentiation, which competes with TCF/LEF binding and inhibits Wnt signalling. It also promotes odontoblast differentiation through LEF1, BMP2 and BMP4 transcription. The CTNNB1 gene belongs to the beta-catenin family and encodes a protein that binds APC. Mutations are a cause of colorectal cancer, pilomatrixoma, medulloblastoma and ovarian cancer, and alternative splicing yields multiple transcript variants.
CTNNB1 is a key downstream component of canonical Wnt signalling, accumulating in the nucleus to coactivate TCF/LEF target genes when Wnt ligand is present.
As part of the E-cadherin:catenin complex, CTNNB1 links adherens junctions to the actin cytoskeleton and helps maintain epithelial cell layers.
Mutations in CTNNB1 are a cause of colorectal cancer, pilomatrixoma, medulloblastoma and ovarian cancer, and the protein binds the APC gene product.
CTNNB1 contributes to neurogenesis, chondrocyte differentiation and odontoblast differentiation during tooth germ formation, and promotes EMT and MET through TCF target genes.
CTNNB1 acts as a transcriptional coactivator in canonical Wnt signalling, working with TCF/LEF factors to activate Wnt-responsive genes. It is also a component of the E-cadherin:catenin adhesion complex at adherens junctions, where it helps anchor the actin cytoskeleton and regulate cell adhesion.
CTNNB1 is commonly called beta-catenin. Other aliases include armadillo and CTNNB, and the full HGNC name is catenin beta 1. Older names describe it as a cadherin-associated protein, beta 1, 88kD. Alternative splicing produces multiple transcript variants of the CTNNB1 gene.
Mouse and rat both have a Ctnnb1 ortholog, so the protein can be studied in rodent models; check the datasheet of any product for its validated reactivity. In humans, CTNNB1 mutations are a cause of colorectal cancer, pilomatrixoma, medulloblastoma and ovarian cancer.
Pathway partners and regulators of beta-catenin signalling with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P35222; product specifications from Assay Genie datasheets.